## **Core Concept**
Visceral Leishmaniasis, also known as kala-azar, is a severe form of Leishmaniasis that affects the internal organs. The disease is caused by *Leishmania* parasites, which are transmitted by the bite of infected sandflies. The first-line treatment for visceral Leishmaniasis involves medications that target the parasite.

## **Why the Correct Answer is Right**
The correct answer, **C. Amphotericin B**, is a polyene antifungal medication that is also effective against *Leishmania* parasites. It works by binding to ergosterol in the parasite's cell membrane, leading to cell death. Amphotericin B is considered a first-line treatment for visceral Leishmaniasis, especially in cases where antimonial compounds are not effective or cannot be used.

## **Why Each Wrong Option is Incorrect**
* **Option A:** is not the correct answer because, although it might have some antimicrobial properties, it is not the drug of choice for visceral Leishmaniasis.
* **Option B:** is incorrect because, while it has various applications, it is not primarily used for treating visceral Leishmaniasis.
* **Option D:** is not the correct answer because it is not typically used as a first-line treatment for visceral Leishmaniasis.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that the treatment for visceral Leishmaniasis may vary depending on the region and the specific *Leishmania* species involved. However, Amphotericin B and miltefosine are commonly used as first-line treatments. It's also important to note that antimonial compounds, such as sodium stibogluconate, were historically the mainstay of treatment but have seen reduced efficacy in some regions due to resistance.

## **Correct Answer:** . Amphotericin B